Voltage gated ion channels: Targets for anticonvulsant drugs

Current Topics in Medicinal Chemistry

Volumn 5, Issue 1, 2005, Pages 15-30

  Errington, Adam C ^a,c   Stöhr, Thomas ^b   Lees, George ^a,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Schwarz Pharma AG   (Germany)

^c UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Anticonvulsants; Epilepsy; Voltage gated ion channels

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM ION; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; LOSIGAMONE; MEMBRANE PROTEIN; OXCARBAZEPINE; PHENYTOIN; POTASSIUM ION; PRIMIDONE; RETIGABINE; SAFINAMIDE; SIPATRIGINE; SODIUM ION; TOPIRAMATE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ANTICONVULSANT ACTIVITY; BRAIN REGION; CALCIUM CONDUCTANCE; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; CLINICAL TRIAL; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; EPILEPSY; EPILEPTIC DISCHARGE; FEMALE; GENE MUTATION; HEAD INJURY; HEREDITY; HUMAN; NERVE CELL; NERVE CELL EXCITABILITY; NONHUMAN; OOCYTE; PATHOGENESIS; PATHOPHYSIOLOGY; POTASSIUM CONDUCTANCE; PREVALENCE; RAT; REVIEW; SEIZURE; SODIUM CONDUCTANCE; STRUCTURE ACTIVITY RELATION; SYMPTOM; XENOPUS;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNELS; ELECTROPHYSIOLOGY; HUMANS; ION CHANNEL GATING; ION CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; SODIUM CHANNELS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 13444291643     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026053386872     Document Type: Review

References (131)

1. Traub, R. D.; Borck, C.; Colling, S. B.; Jefferys, J. G. On the structure of ictal events in vitro. Epilepsia 1996, 37 879-891.
2. Jefferys, J. G. R. Models and Mechanisms of Experimental Epilepsies. Epilepsia 2003, 44, 44-50.
3. Hodgkin, A. L.; Huxley, A. F. The dual effect of membrane potential on sodium conductance in the giant axon of Loligo. J. Physiol. (London) 1952, 116, 497-506.
4. Hodgkin, A. L.; Huxley, A. F. The components of membrane conductance in the giant axon of Loligo. J. Physiol (London) 1952, 116, 473-496.
5. Hodgkin, A. L.; Huxley, A. F. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J. Phsiol. (London) 1952, 116, 473-506.
6. + channels. Physiol. Rev. 1992, 72, S15-S48.
7. Catterall, W. A. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv. Neurol. 1999, 79, 441-456.
8. Qu, Y.; Curtis, R.; Lawson, D.; Gilbride, K.; Ge, P.; DiStefano, P.S.; Silos-Santiago, I.; Catterall, W. A.; Scheuer, T. Differential modulation of sodium channel gating and persistant sodium currents by the β1, β2 and β3 subunits. Mol. Cell. Neurosci. 2001, 18, 570-580.
9. Goldin, A. L.; Barchi, R. L.; Caldwell, J. H.; Hofmann, F.; Howe, J. R.; Hunter, J. C.; Kallen, R. G.; Mandel, G.; Meisler, M. H.; Netter, Y. B.; Noda, M.; Tamkun, M. M.; Waxman, S. G.; Wood, J.N.; Catterall, W. A. Nomenclature of voltage-gated sodium channels. Neuron 2000, 28, 365-368.
10. Noda, M.; Ikeda, T.; Kayano, T.; Suzuki, H.; Takeshima, M.; Kurasaki, H.; Takahashi, S.; Numa, S. Existence of distinct sodium channel messenger RNAs in rat brain. Nature 1986, 320, 121-127.
11. Ragsdale, D. S.; Avoli, M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Rev. 1998, 26 16-28.
12. Catterall, W. A. A 3D view of sodium channels. Nature 2001, 409, 988-991.
13. Hille, B. Ion channels of excitable membranes; Sinauer Assoc.: Sunderland, MA., 1992.
14. Hodgkin, A. L.; Huxley, A. F. A quantative description of membrane current and its application to conduction and excitation in nerve. J. Physiol (Lond) 1952, 117, 500-544.
15. Armstrong, C. M.; Bezanilla, F. Charge movement associated with the opening and closing of the activation gates of Na channels. J. Gen. Physiol. 1974, 63, 533-552.
16. Armstrong, C. M.; Bezanilla, F. Currents related to the movement of the gating particles of the sodium channels. Nature 1973, 242, 459-461.
17. Stümer, W.; Conti, F.; Suzuki, X.; Wang, M.; Noda, M.; Yahadi, N.; Kubo, H.; Numa, S. Structural parts involved in activation and inactivation of the voltage gated sodium channel. Nature 1989, 339, 597-603.
18. Patton, D. E.; West, J. W.; Catterall, W. A.; Goldin, A. L. Amino acid residues required for fast Na+ channel inactivation: charge neutralizations and deletions in the III-IV linker, Proc. Nat. Acad Sci. U. S. A. 1992, 89, 10905-10909.
19. Vassilev, P. M.; Scheuer, T.; Catterall, W. A. Identification of an intracellular peptide segment involved in sodium channel inactivation. Science 1988, 241, 1658-1661.
20. + channel inactivation. Proc. Nat. Acad. Sci. U. S. A. 1992, 89, 10910-10914.
21. McPhee, J. C.; Ragsdale, D. S.; Scheuer, T.; Catterall, W. A. A critical role for transmembrane segment IVS6 of the sodium channel α subunit in fast inactivation. J. Biol. Chem. 1995, 270, 12025-12034.
22. Goldin, A. L. Mechanisms of sodium channel inactivation. Curr. Opin. Neurobiol. 2003, 13, 284-290.
23. Traub, R. D.; Jefferys, G. R.; Whittington, M. A. Fast Oscillations in Cortical Circuits.; The MIT Press: Cambridge, MA, 1999.
24. Featherstone, I. A.; Richmond, J. E.; Ruben, P. C. Interaction between fast and slow inactivation in Skm1 sodium channels. Biophys. J. 1996, 71, 3098-3109.
25. Richmond, J. E.; Featherstone, I. A.; Hartmann, H. A.; Ruben, P. C. Slow inactivation in human cardiac sodium channels. Biophys. J. 1998, 74, 2945-2952.
26. Fleidervish, I. A.; Friedman, A.; Gutnick, M. J. Slow inactivation of Na+ current and slow cumulative spike adaptation in mouse and guinea pig neocortical neurones in slices. J. Physiol. 1996 493, 83-97.
27. + channels. J. Neurosci. 1998, 18, 1893-1903.
28. Avoli, M.; Barbarosie, M.; Lucke, A.; Nagao, T.; Lopantsev, V.; Kohling, R. Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J. Neurosci. 1996 16, 3912-3924.
29. Lopantsev, V.; Avoli, M. Participation of GABAA-mediated inhibition in ictal-like discharges in the rat entorhinal cortex. J. Neurophysiol. 1998, 79, 352-360.
30. Avoli, M.; D'Antuono, M.; Louvel, J.; Kohling, R.; Biagini, G.; Pumain, R.; D'Arcangelo, G.; Tancredi, V. Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. Prog. Neurobiol. 2002, 68, 167-207.
31. Dougalis, A.; Lees, G.; Ganellin, C. R. The sleep lipid oleamide may represent and endogenous anticonvulsant: an in vitro comparative study in the 4-aminopyridine rat brain slice model. Neuropharmacology 2003.
32. Taylor, C. P. Na+ currents that fail to inactivate. Trends Neurosci. 1993, 16, 455-460.
33. + current in pyramidal neurons from rat and cat sensorimotor coretx. J. Neurosci. 1993 13, 660-673.
34. + currents is compatible with modal gating hypothesis for sodium channels. J. Neurophysiol. 1994, 71, 2562-2565.
35. + conductance in rat cortical neurons: appearance of a slowly inactivating component. J. Neurophysiol. 1988, 59 778-795.
36. Crill, W. E. Persistant sodium current in mammalian central nervous system. Annu. Rev. Physiol. 1996, 58, 349-362.
37. Stafstrom, C. E.; Schwindt, P. C.; Chubb, M. C.; Crill, W. E. Properties of persistant sodium conductance and calcium conductance of layer V neurons from cat sensorimotor coretx in vitro. J. Neurophysiol. 1985, 53, 152-170.
38. Stafstrom, C. E.; Schwindt, P. C.; Crill, W. E. Negative slope conductance due to a persistant subthreshold sodium current in cat neocortical neurons in vitro. Brain Res. 1982, 236, 221-226.
39. + channels: an unexpected form of cellular plasticity. Nat. Rev. Neurosci. 2001, 2, 397-407.
40. Murphy, B. J.; Rossie, S.; DeJongh, K. S.; Catterall, W. A. Identification of sites of selective phosphorylation and dephosphorylation of the rat brain sodium channel α subunit by cAMP dependent protein kinase and phosphoprotein phosphatases. J. Biol. Chem. 1993, 268, 27355-27362.
41. Smith, R. D. Goldin, A. L. Phosphorylation of brain sodium channels in the I-II linker modulates function in Xenopus oocytes. J. Neurosci. 1996, 16, 1965-1974.
42. Li, M.; West, J. W.; Lai, Y.; Scheuer, T.; Catterall, W. A. Functional modulation of brain sodium channels by cAMP-dependent phosphorylation. Neuron 1992, 8, 1151-1159.
43. Alroy, G.; Su, H.; Yaari, Y. Protein kinase C mediates muscarinic block of intrinsic bursting in rat hippocampal neurons. J. Physiol. 1999, 518, 71-79.
44. Azouz, R.; Jensen, M. S.; Yaari, Y. Muscarinic modulation of of intrinsic burst firingi in rat hippocampal neurons. Eur. J. Neurosci. 1994, 6, 961-966.
45. Merritt, H. H.; Putnam, T. J. Sodium diphenylhydantoinate in the treatment of convulsive disorders. J. Am. Med. Assoc. 1938 111, 1068-1073.
46. Brodie, M. J.; Dichter, M. A. Antiepileptic drugs. N. Engl. J. Med 1996, 334, 168-175.
47. Toman, J. E. P. The neuropharmacology of antiepileptics. Electroencephalogr. Clin. Neurophysiol. 1949, 1, 33-44.
48. McLean, M. J.; McDonald, R. L. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 1986, 237, 779-789.
49. Willow, M.; Gonoi, T.; Catterall, W. A. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol. Pharmacol. 1985, 27, 549-558.
50. Matsuki, N.; Quandt, F. N.; Ten Eick, R. E.; Yeh, J. Z. Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 1984, 228 523-530.
51. Taylor, C. P.; Meldrum, B. S. Na+ channels as targets for neuroprotective drugs. Trends Pharmacol. Sci. 1995, 16, 309-315.
52. Lang, D. G.; Wang, C. M.; Cooper, B. R. Lamotrigine, Phenytoin and Carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 1993 266, 829-834.
53. Chao, T. I.; Alzheimer, C. Effects of phenytoin on the persistent Na+ current of mammalian CNS neurones. Neuroreport 1995, 6, 1778-1780.
54. Lampl, I.; Schwindt, P.; Crill, W. Reduction of Cortical Pyramidal Neuron Excitability by the Action of Phenytoin on Persistent Na+ Current. J. Pharmacol. Exp. Ther. 1998, 284, 228-237.
55. NaP in cortical neurons. Neuroreport 2002, 13, 1167-1170.
56. Kuo, C. C. A Common Anticonvulsant Binding Site for Phenytoin, Carbamazepine, and Lamotrigine in Neuronal Na+ Channels. Mol. Pharmacol. 1998, 54, 712-721.
57. Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Anti-epileptic drug development. II. Anticonvulsant drug screening. Epilepsia 1978, 19, 404-428.
58. Meldrum, B. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res. 2002, 50, 33-40.
59. McLean, M. J.; McDonald, R. L. Carbamazepine and 10,11-epoxycarbamazepine produce use and voltage dependent limitation of rapidly firing action potentials in mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 1986, 238, 727-738.
60. + currents: quantitative distinction from phenytoin and possible clinical implications. Mol. Pharmacol. 1977, 51, 1077-1083.
61. Tecoma, E. S. Oxcarbazepine. Epilepsia 1999, 40, S37-S46.
62. Bonifácio, M. J.; Sheridan, R. D.; Parada, A.; Cunha, R. A.; Patmore, L.; Soares-da-Silva, P. Interaction of the novel anticonvulsant, BIA 2-093, with voltage gated sodium channels: comparison with carbamazepine. Epilepsia 2001, 42, 600-608.
63. Leach, M. J.; Baxter, M. G.; Critchley, M. A. E. Neurochemical and behavioural aspects of Lamotrigine. Epilepsia 1991, 32, S4-S8.
64. Leach, M. J.; Marden, C. M.; Miller, A. A. Pharmacological studies on Lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia 1986 27, 490-497.
65. Miller, A. A.; Wheatly, P.; Sawyer, D. A.; Baxter, M. G.; Roth, B. Pharmacological studies on lamotrigine, a novel potential antiepiletic drug: I. Anticonvulsant profile in mice and rats. Epilepsia 1986, 27, 4183-489.
66. Hamill, O. P.; Marty, A.; Neher, E.; Sakmann, B.; Sigworth, F. J. Improved patch clamp techniques for high-resolution current recordings from cells and cell free memebrane patches. Pflug. Arch. 1981, 391, 85-100.
67. Lees, G.; Leach, M. J. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex. Brain Research 1993, 612, 190-199.
68. Wang, C. M.; Lang, D. G.; Cooper, B. R. Lamotrigine effects on ion channels in neuronal cells. Epilepsia 1993, 34, 117-118.
69. Ragsdale, D. S.; McPhee, J. C.; Scheuer, T.; Catterall, W. A. Molecular determinants of state-dependent block of Na channels by local anesthetics. Science 1994, 265, 1724-1728.
70. Ragsdale, D. S.; McPhee, J. C.; Scheuer, T.; Catterall, W. A. Common molecular determinants of local anesthetic, antiarrhythmic and anticonvulsant block of voltage gated Na channels. Proc. Nat. Acad. Sci. U. S. A. 1996, 93, 9270-9275.
71. Shank, R. P.; Gardocki, J. F.; Vaught, J. L.; Davis, C. B.; Schupsky, J. J.; Raffa, R. B.; Dodgson, S. J.; Nortey, S. O.; Maryanoff, B. E. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 1994, 35, 450-460.
72. Gibbs, J. W. III; Sombati, S.; DeLorenzo, R. J.; Coulter, D. A. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000, 41, S10-S16.
73. Brown, S. D.; Wolf, H. H.; Swinyard, E. A.; Twyman, R. E.; White, H. S. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia 1993, 34, 123-124.
74. DeLorenzo, R. J.; Sombati, S.; Coulter, D. A. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia 2000, 41, S40-S44.
75. Zona, C.; Ciotti, M. T.; Avoli, M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 1997, 231, 123-126.
76. Taverna, S.; Sancini, G.; Mantegazza, M.; Franceschetti, S.; Avanzini, G. Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate. J. Pharmacol. Exp. Ther. 1999, 288, 960-968.
77. Draguhn, A.; Jungclaus, M.; Sokolowa, S.; Heinemann, U. Losigamone decreases spontaneous synaptic activity in cultured hippocampal neurons. Eur. J. Pharmacol. 1997, 325, 245-251.
78. Gebhardt, C.; Breustedt, J. M.; Noldner, M.; Chatterjee, S. S.; Heinemann, U. The antiepileptic drug losigamone decreases the persistent Na+ current in rat hippocampal neurons. Brain Res. 2001 920, 27-31.
79. Salvati, P.; Maj, R.; Caccia, C.; Cervini, M. A.; Fornaretto, M. G.; Lamberti, E.; Pevarello, P.; Skeen, G. A.; White, H. S.; Wolf, H.H.; Faravelli, L. Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound. J. Pharmacol. Exp. Ther. 1999, 288, 1151-1159.
80. 2+ channels. Annu. Rev. Cell. Dev. Biol. 2000, 16, 521-555.
81. Ertel, E.; Campbell, K. P.; Harpold, M. M.; Hofmann, F.; Mori,.Y. Nomenclature of voltage-gated calcium channels. Neuron 2000, 25, 533-535.
82. Nowycky, M. C.; Fox, A. P.; Tsien, R. W. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 1985, 316, 440-443.
83. Reuter, H. Calcium channel modulation by neurotransmitters, enzymes and drugs. Nature 1983, 301, 569-574.
84. Llinás, R. Yarom, Y. Electrophysiology of mammalian inferior olive neurones in vitro. Different types of voltage dependent ionic conductances. J. Physiol. 1981, 315, 569-584.
85. McCleskey, E. W.; Fox, A. P.; Feldman, D. H.; Cruz, L. J.; Olivera, B. M.; Tsien, R. W.; Yoshikami, D. (ω-Conotoxin: direct and persistant blockade of specific calcium channels in nuerons but not muscle. Proc. Nat. Acad. Sci. U. S. A. 1987, 84, 4327-4331.
86. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 1995, 15, 2995-3012.
87. Jones, O. T. Ca2+ channels and epilepsy. Eur. J. Pharmacol. 2002, 447, 211-225.
88. Chen, L.; El Husseini, A.; Tomita, S.; Bredt, D. S.; Nicoll, R. A. Stargazin Differentially Controls the Trafficking of {alpha}-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate and Kainate Receptors. Mol. Pharmacol. 2003, 64, 703-706.
89. Coulter, D. A.; Huguenard, J. R.; Prince, D. A. Specific petit mal anticonvulsants reduce calcium currents in thalamic neurons. Neurosci. Lett. 1989, 98, 74-78.
90. Coulter, D. A.; Huguenard, J. R.; Prince, D. A. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurons: calcium current reduction. Br. J. Pharmacol. 1990, 100, 800-806.
91. Gomora, J. C.; Daud, A. N.; Weiergraber, M.; Perez-Reyes, E. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol. Pharmacol. 2001, 60, 1121-1132.
92. Gee, N. S.; Brown, J. P.; Dissanayake, V. U.; Offord, J.; Thurlow, R.; Woodruff, G. N. The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 1996, 271, 768-776.
93. Sutton, K. G.; Martin, D. J.; Pinnock, R. D.; Lee, K.; Scott, R. H. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br. J. Pharmacol. 2002, 135, 257-265.
94. Stefani, A.; Spadoni, F.; Bernardi, G. Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 1998, 37, 83-91.
95. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2001, 42, 229-236.
96. Bayer, K.; Ahmadi, S.; Zeilhofer, H. U. Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology 2004, 46, 743-749.
97. Zhang, X.; Velumian, A. A.; Jones, O. T.; Carlen, P. L. Modulation of high-voltage activated calcium channels in dentate granule cells by topiramate. Epilepsia 2000, 41, S52-S60.
98. Stefani, A.; Spadoni, F.; Siniscalchi, A.; Benardi, G. Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur. J. Pharmacol. 1996, 307, 113-116.
99. MacKinnon, R. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 1991, 350, 232-235.
100. Bezanilla, F. The voltage sensor in voltage-dependent ion channels. Physiol. Rev. 2000, 80, 555-592.
101. Yellen, G. The voltage gated potassium channels and their relatives. Nature 2002, 419, 35-42.
102. MacKinnon, R. Potassium channels. FEBS Lett 2003, 555, 62-65.
103. + channel in rat cortical neurons in culture. Society for neuroscience abstracts 1999, 25, 1868.
104. Zona, C.; Niespodziany, I.; Marchetti, C.; Klitgaard, H.; Bernardi, G.; Margineanu, D. G. Levetiracetam does not modulate neuronal voltage-gated Na+and T-type Ca2+currents. Seizure 2001, 10 279-286.
105. Madeja, M.; Georg Margineanu, D.; Gorji, A.; Siep, E.; Boerrigter, P.; Klitgaard, H.; Speckmann, E. J. Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action? Neuropharmacology 2003, 45, 661-671.
106. Zona, C.; Tancredi, V.; Longone, P.; D'Arcangelo, G.; D'Antuono, M.; Manfredi, M.; Avoli, M. Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine. Epilepsia 2002 43, 685-690.
107. Zona, C.; Tancredi, V.; Palma, E.; Pirrone, G. C.; Avoli, M. Potassium currents in rat cortical neurons in culture are enhanced by the antiepileptic drug carbamazepine. Can. J. Physiol. Pharmacol, 1990, 68, 545-547.
108. + current in a vertebrate neuron. Nature 1980, 283, 673-676.
109. Halliwell, J. V.; Adams, P. R. Voltage clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 1982 250, 71-92.
110. Wang, H. S.; Pan, Z.; Shi, W.; Brown, B. S.; Wymore, R. S.; Cohen, I. S.; Dixon, J. E.; McKinnon, D. KNCQ2 and KNCQ3 potassium channels subunits: molecular correlates of the M-channel. Science 1998, 282, 1890-1893.
111. Robbins, J. KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol. Ther. 2001, 90, 1-19.
112. Charlier, C.; Singh, N. A.; Ryan, S. G.; Lewis, T. B.; Reus, B. E.; Leach, R. J.; Leppert, M. A pore mutation in an idiopathic epilepsy family. Nat. Genet. 1998, 18, 53-55.
113. Biervert, C.; Schroeder, B. C.; Kubisch, C.; Berkovic, S. F.; Propping, P.; Jentsch, T. J.; Steinlein, O. K. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279, 403-406.
114. + channels causes epilepsy. Nature 1998, 396, 687-690.
115. Rundfeldt, C. The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells. Eur. J. Pharmacol. 1997, 336, 243-249.
116. Rundfeldt, C.; Netzer, R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neurosci. Lett. 2000, 282, 73-76.
117. Goldstein, S. A. N.; Bockenhauer, D.; O'Kelly, I.; Zilberberg, N. Potassium leak channels and the KNCK family of two-P-domain subunits. Nat. Rev. Neurosci. 2001, 2, 175-184.
118. Meadows, H. J.; Chapman, C. G.; Duckworth, D. M.; Kelsell, R. E.; Murdock, P. R.; Nasir, S.; Rennie, G.; Randall, A. D. The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK. Brain Res. 2001 892, 94-101.
119. Singh, N. A.; Westenskow, P.; Charlier, C.; Pappas, C.; Leslie, J.; Dillon, J.; Anderson, V. E.; Sanguinetti, M. C.; Leppert, M. F. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulssions: expansion of the functional mutation spectrum. Brain 2003, 126, 2726-2737.
120. Hirose, S.; Zenri, F.; Akiyoshi, H.; Fukama, G.; Iwata, H.; Inoue, T.; Yonetani, M.; Tsutsumi, M.; Muranaka, H.; Kurokawa, T.; Hanai, T.; Wada, K.; Kaneko, S.; Mitsudome, A. A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions. Ann. Neurol. 2000, 47, 822-826.
121. Vijai, J.; Kapoor, A.; Ravishankar, H. M.; Cherian, P. J.; Girija, A. S.; Rajendran, B.; Rangan, G.; Jayalakshmi, S.; Mohandas, S.; Radhakrishnan et, a. Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy in a South Indian population. Human Genetics 2003, 113, 461-463.
122. Wallace, R. H.; Scheffer, I. E.; Barnett, S.; Richards, M.; Dibbens, L.; Desai, R. R.; Lerman-Sagie, T.; Lev, D.; Mazarib, A.; Brand, N.; Ben-Zeev, B.; Goikhman, I.; Singh, R.; Kremmidiotis, G.; Gardner, A.; Sutherland, G. R.; George, A. L. J.; Mulley, J. C.; Berkovic, S. F. Neuonal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am. J. Hum. Genet. 2001. 68 859-865.
123. Spampanato, J.; Escayg, A.; Meisler, M. H.; Goldin, A. L. Functional effects of two voltage gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J Neurosci. 2001, 21, 7481-7490.
124. +)-channel alpha 1 subunit gene, SCN1A. Epilepsy Res. 2002, 48, 15-23.
125. Ceulemans, B. P.; Claes, L. R.; Lagae, L. G. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy. Pediatr. Neurol. 2004, 30, 236-243.
126. Sugawara, T.; Tsurubuchi, Y.; Fujiwara, T.; Mazaki-Miyazaki, E.; Nagata, K.; Montal, M.; Inoue, T.; Yamakawa, K. Nav1.1 channels with mutations of severe myoclonic epilepsy in infancy display attenuated currents. Epilepsy Res. 2003, 54, 201-207.
127. Sugawara, T.; Tsurubuchi, Y.; Agarwala, K. L.; Ito, M.; Fukuma, G.; Mazaki-Miyazaki, E.; Nagafuji, H.; Noda, M.; Imoto, K.; Wada, K.; Mitsudome, A.; Kaneko, S.; Montal, M.; Nagata, K.; Hirose, S.; Yamakawa, K. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Nat. Acad. Sci. U. S. A. 2001, 98, 6384-6389.
128. Berkovic, S. F.; Heron, S. E.; Giordano, L.; Marini, C.; Guerrini, R.; Kaplan, R. E.; Gambardella, A.; Steinlein, O. K.; Grinton, B. E.; Dean, J.T.; Bordo, L. Hodgson, B.L.; Yamamoto, T.; Mulley, J.C.; Zara, F.; Scheffer, I.E. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann. Neurol. 2004, 55, 550-557.
129. Wallace, R. H.; Scheffer, I. E.; Parasivam, G.; Barnett, S.; Wallace, G. B.; Sutherland, G. R.; Berkovic, S. F.; Mulley, J. C. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology 2002, 58, 1426-1429.
130. Chioza, B.; Osei-Lah, A.; Nashef, L.; Suarez-Merino, B.; Wilkie, H.; Sham, P.; Knight, J.; Asherson, P.; Makoff, A. J. Haplotype and linkage disequilibrium analysis to characterise a region in the calcium channel gene CACNA1A associated with idiopathic generalised epilepsy. Eur. J. Hum. Genet.: EJHG 2002, 10, 857-864.
131. Khosravani, H.; Altier, C.; Simms, B.; Hamming, K. S.; Snutch, T. P.; Mezeyova, J.; McRory, J. E.; Zamponi, G. W. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy. J. Biol. Chem. 2004, 279, 9681-9684.